Amphastar Pharmaceuticals, Inc.
AMPH· Nasdaq
AMPHAmphastar Pharmaceuticals, Inc.
Filed Aug 13, 2015 · 10-Q · 44 days after period end · 0001171843-15-004674
| Metric | Q2 2015 | Q2 2014 | Q2 2013 |
|---|---|---|---|
| Revenue | $53.85M | $49.00M | $62.52M |
| Net Income | -$6.65M | -$1.18M | $7.81M |
| EPS Diluted | -$0.15 | -$0.03 | $0.20 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Amphastar Pharmaceuticals, Inc. · CIK 1297184 · Engraved from SEC EDGAR
ended Jun 30, 2015 · filed Aug 13, 2015 · 44 d after period end
